Vol. 102 No. 8 (2017): August, 2017 | Haematologica
Haematologica, Volume 107, Issue 7 by Haematologica - Issuu
Haematologica, Volume 104, Issue 3 by Haematologica - Issuu
Haematologica, Volume 106, Issue 9 by Haematologica - Issuu
Haematologica, Volume 107, Issue 11 by Haematologica - Issuu
American Journal of Hematology | Blood Research Journal | Wiley Online Library
Haematologica, Volume 105, issue 2 by Haematologica - Issuu
![PDF] Pathophysiology and treatment of patients with beta-thalassemia – an update | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/44d24730e45badafae7882562e6d62f83daf7632/8-Figure1-1.png "PDF] Pathophysiology and treatment of patients with beta-thalassemia – an update | Semantic Scholar")
PDF] Pathophysiology and treatment of patients with beta-thalassemia – an update | Semantic Scholar
Vol. 102 No. 5 (2017): May, 2017 | Haematologica
Haematologica, Volume 106, Issue 2 by Haematologica - Issuu
Cancers | Free Full-Text | Targeting Leukemia-Initiating Cells and Leukemic Niches: The Next Therapy Station for T-Cell Acute Lymphoblastic Leukemia?
American Journal of Hematology | Blood Research Journal | Wiley Online Library
IJMS | Free Full-Text | Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia
Haematologica, Volume 102, issue 11 by Haematologica - Issuu
Efficient manufacturing and engraftment of CCR5 gene-edited HSPCs following busulfan conditioning in nonhuman primates: Molecular Therapy - Methods & Clinical Development
Efficient manufacturing and engraftment of CCR5 gene-edited HSPCs following busulfan conditioning in nonhuman primates: Molecular Therapy - Methods & Clinical Development
Residual erythropoiesis protects against myocardial hemosiderosis in transfusion-dependent thalassemia by lowering labile plasma iron via transient generation of apotransferrin | Haematologica
The evolving treatment landscape for children with sickle cell disease - The Lancet Child & Adolescent Health
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia | NEJM
Benefits and Risks in Polypathology and Polypharmacotherapy Challenges in the Era of the Transition of Thalassaemia from a Fatal to a Chronic or Curable Disease
Haematologica, Volume 104, Issue 5 by Haematologica - Issuu
Cells | Free Full-Text | Eltrombopag Improves Erythroid Differentiation in a Human Induced Pluripotent Stem Cell Model of Diamond Blackfan Anemia
Cancers | Free Full-Text | Mechanisms of Immune Evasion in Acute Lymphoblastic Leukemia
Haematologica, Volume 104, Issue 4 by Haematologica - Issuu
New therapeutic targets in transfusion-dependent and -independent thalassemia. - Abstract - Europe PMC
Vol. 102 No. 4 (2017): April, 2017 | Haematologica
